MAIA Biotechnology CEO Vlad Vitoc's 2023 pay rises 18% to $1.4M
MAIA Biotechnology reports 2023 executive compensation
By ExecPay News
Published: April 16, 2024
MAIA Biotechnology reported fiscal year 2023 executive compensation information on April 16, 2024.
In 2023, five executives at MAIA Biotechnology received on average a compensation package of $844K, a 5% decrease compared to previous year.
Average pay of disclosed executives at MAIA Biotechnology
Vlad Vitoc, Chief Executive Officer, received $1.4M in total, which increased by 18% compared to 2022. 63% of Vitoc's compensation, or $901K, was in option awards. Vitoc also received $473K in salary and $57K in other compensation.
Mihail Obrocea, Chief Medical Officer, received a compensation package of $973K, which increased by 14% compared to previous year. 51% of the compensation package, or $499K, was in option awards.
Sergei Gryaznov, Chief Scientific Officer, earned $895K in 2023, a 16% increase compared to previous year.
Joseph F. McGuire, Chief Financial Officer, received $845K in 2023, which increases by 15% compared to 2022.
Jeffrey C. Himmelreich, Head of Finance, earned $78K in 2023.
Related executives
You may also like
Source: SEC filing on April 16, 2024.